2019
Notice of Annual General Meeting/Proxy Form incl. Annual Report
ANP – Appendix 3B – 29 Oct 2019
Neuromuscular Drug Development Summit Poster Presentation
ANP – Appendix 4C – 30 Sept 19_final
ANP to present at Neuromuscular Drug Development Summit in USA
ANP – Appendix 3B – 04 Oct 2019
Positive Preliminary results from ATL1102 for DMD Phase II trial
ATL1102 for DMD commencement of European regulatory interactions
ATL1102 Phase II clinical trial in DMD update
Conference Presentation June 2019
ATL1102 Phase II clinical trial in DMD final enrolment
ATL1102 Phase II clinical trial in DMD update
Placement to Accelerate Development of ATL1102 in DMD
ASX 19_30 Jan_ANP – Appendix 4C – 31 Dec 18
ASX 19_23 Jan_Updated Company Presentation
ASX 19_ 18 January ATL1102 Phase II clinical trial in DMD update_Final
2018
ASX 18_29 Nov_Results of Meeting
ASX 18_29 Nov_AGM Presentation
ANP_Appendix 4G_9 November 2018
ASX 18_Change of Directors Interest Notice (MD)
ASX 18_Change of Directors Interest Notice (RM)
ASX 18_ 29 October_Notice of Meeting_including Annual Report
ASX 18_16 October_Price query response
ASX 18_6 September_Duchenne ACTT Now
ASX 18_29 August_ANP Dosing ATL1102 Phase II clinical trial in DMD
ANP – Appendix 3Y – RM – 26 July 2018
ASX 18_16 July_AL1102 Phase II DMD trial
121 Tech Investment Hong Kong conference presentation June 2018
ASX 18_14 June_EAP Update_ATL1103
Change of Director’s Interest Notice_(WG)
ASX 18_23 May__ATL1103 Journal of Endo publication
Change of Director’s Interest Notice_(RM, MD, GP, WG, GM)
ANP – Appendix 3B – 9 May 2018
ASX 18_7 May_Top 20 & Distribution Schedule
ANP – Appendix 3B – 7 May 2018_FINAL
ASX 18_3 May_Entitlement offer_Completion of Capital Raising
ASX 18_1 May 2018_Investor Presentation
Appendix 4C_Quarterly Cashflow Report
ANP – Cleansing Notice – Rights Issue_16 April 2018
Becoming a Substantial Shareholder AEI
ASX 18_6 April_Letters to Shareholders & Optionholders
ASX 18_6 April_Cleansing Notice
ASX 18_6 April_Entitlement Offer
ASX 18_ 6 April_Placement Completion and Entitlement Offer
ASX 18_ 3 April_Institutional Placement & Rights Issue
ASX 18_28 February ATL1102 Ethics Committe Approval
ANP-Appendix 4D_31 December 2017
ASX 18_26 February_EAP Update_ATL1103
ANP – Appendix 4C – 31 December 17
2017
View the 2017 announcements on the ASX website
